Tumor immunology: Basic and clinical advances

Pamela L. Beatty, Sandra Cascio, Eric Lutz

Research output: Contribution to journalArticle

Abstract

The third in a series of AACR conferences, entitled "Tumor Immunology: Basic and Clinical Advances," was held in Miami Beach, Florida from November 30 to December 3, 2010. The overall objective of this meeting was to discuss rapid developments in the understanding of basic principles of antitumor immunity and strategies for increasing the success rate of cancer immunotherapy. The key findings that emerged from the meeting included (i) that integrated approaches are required for the development of effective cancer immunotherapies and (ii) attention should be on multiple cellular and molecular components and their broader networks rather than on a single pathway or cell type.

Original languageEnglish (US)
Pages (from-to)4338-4343
Number of pages6
JournalCancer Research
Volume71
Issue number13
DOIs
StatePublished - Jul 1 2011

Fingerprint

Allergy and Immunology
Immunotherapy
Neoplasms
Immunity

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Tumor immunology : Basic and clinical advances. / Beatty, Pamela L.; Cascio, Sandra; Lutz, Eric.

In: Cancer Research, Vol. 71, No. 13, 01.07.2011, p. 4338-4343.

Research output: Contribution to journalArticle

Beatty, PL, Cascio, S & Lutz, E 2011, 'Tumor immunology: Basic and clinical advances', Cancer Research, vol. 71, no. 13, pp. 4338-4343. https://doi.org/10.1158/0008-5472.CAN-11-0717
Beatty, Pamela L. ; Cascio, Sandra ; Lutz, Eric. / Tumor immunology : Basic and clinical advances. In: Cancer Research. 2011 ; Vol. 71, No. 13. pp. 4338-4343.
@article{24421e81118f4ba3b26f31e5be464f25,
title = "Tumor immunology: Basic and clinical advances",
abstract = "The third in a series of AACR conferences, entitled {"}Tumor Immunology: Basic and Clinical Advances,{"} was held in Miami Beach, Florida from November 30 to December 3, 2010. The overall objective of this meeting was to discuss rapid developments in the understanding of basic principles of antitumor immunity and strategies for increasing the success rate of cancer immunotherapy. The key findings that emerged from the meeting included (i) that integrated approaches are required for the development of effective cancer immunotherapies and (ii) attention should be on multiple cellular and molecular components and their broader networks rather than on a single pathway or cell type.",
author = "Beatty, {Pamela L.} and Sandra Cascio and Eric Lutz",
year = "2011",
month = "7",
day = "1",
doi = "10.1158/0008-5472.CAN-11-0717",
language = "English (US)",
volume = "71",
pages = "4338--4343",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "13",

}

TY - JOUR

T1 - Tumor immunology

T2 - Basic and clinical advances

AU - Beatty, Pamela L.

AU - Cascio, Sandra

AU - Lutz, Eric

PY - 2011/7/1

Y1 - 2011/7/1

N2 - The third in a series of AACR conferences, entitled "Tumor Immunology: Basic and Clinical Advances," was held in Miami Beach, Florida from November 30 to December 3, 2010. The overall objective of this meeting was to discuss rapid developments in the understanding of basic principles of antitumor immunity and strategies for increasing the success rate of cancer immunotherapy. The key findings that emerged from the meeting included (i) that integrated approaches are required for the development of effective cancer immunotherapies and (ii) attention should be on multiple cellular and molecular components and their broader networks rather than on a single pathway or cell type.

AB - The third in a series of AACR conferences, entitled "Tumor Immunology: Basic and Clinical Advances," was held in Miami Beach, Florida from November 30 to December 3, 2010. The overall objective of this meeting was to discuss rapid developments in the understanding of basic principles of antitumor immunity and strategies for increasing the success rate of cancer immunotherapy. The key findings that emerged from the meeting included (i) that integrated approaches are required for the development of effective cancer immunotherapies and (ii) attention should be on multiple cellular and molecular components and their broader networks rather than on a single pathway or cell type.

UR - http://www.scopus.com/inward/record.url?scp=79959892322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79959892322&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-11-0717

DO - 10.1158/0008-5472.CAN-11-0717

M3 - Article

C2 - 21712409

AN - SCOPUS:79959892322

VL - 71

SP - 4338

EP - 4343

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 13

ER -